Stay updated on Pembrolizumab for Intermediate Risk NMIBC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Intermediate Risk NMIBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Intermediate Risk NMIBC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page no longer displays links or sections for bladder cancer, related topics, and MedlinePlus Genetics, reducing navigational references to these topics on the study page.
    Difference
    0.2%
    Check dated 2026-06-01T01:07:38.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    New navigation items were added to the page: 'Bladder cancer' and a 'related topics' section featuring 'MedlinePlus Genetics', providing additional context and links to related resources.
    Difference
    0.2%
    Check dated 2026-05-24T13:24:30.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision note updated to v3.5.4, replacing v3.5.3 and signaling a minor update to the page's documentation.
    Difference
    0.1%
    Check dated 2026-05-17T08:42:10.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Removal of items in the Related topics section, specifically Bladder cancer and MedlinePlus Genetics. This alters the navigation and topic tagging on the page, while the core study information remains unchanged.
    Difference
    0.2%
    Check dated 2026-05-10T09:20:28.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Bladder cancer is added as a related topic on the page, and MedlinePlus Genetics is listed under related topics to link the study to broader cancer and genetics resources.
    Difference
    0.2%
    Check dated 2026-05-03T01:44:35.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The page’s footer/version label was updated to “Revision: v3.5.3,” and a related-topics section entry referencing “Bladder cancer” and “MedlinePlus Genetics” was removed.
    Difference
    0.2%
    Check dated 2026-04-25T18:44:24.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Intermediate Risk NMIBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Intermediate Risk NMIBC Clinical Trial page.